Correlation of serum uric acid with severity of airflow limitation in the patients of chronic obstructive pulmonary disease


  • Sujit Kumar Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
  • Vimal Kumar Nishad Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
  • Amitabh Das Shukla Department of Pulmonary Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
  • Santosh Kumar Chaudhary Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India



Disease severity, GOLD staging, Uric acid


Background: Serum uric acid (sUA) levels were previously found to be correlated with hypoxic states. We aimed to determine the levels of sUA in COPD patients and to evaluate whether sUA level can be used as predictors of exacerbation risk and disease severity.

Methods: This cross-sectional study included COPD patients and healthy controls. The sUA levels in each group were evaluated and their correlations with the study parameters were investigated. ROC analyses for exacerbation risk were reported.

Results: The study included 106 COPD patients and 110 healthy controls. The mean sUA levels were significantly higher in patients with COPD compared to healthy controls (p<0.05). Mean sUA levels were compared with different stages of COPD according to GOLD criteria. Stage 4 COPD subjects had highest sUA levels compared to other stages. Statistically significant trend was observed for GOLD staging of disease (p<0.05). Surprisingly non-smokers were having higher uric acid level than smokers (p<0.05). The ROC analyses indicated that sUA levels can be useful in predicting exacerbation risk (AUC, 0.412) especially at higher cut-off values, but with low specificity.

Conclusions: Study suggested that sUA levels increased in patients with COPD compared to healthy controls. At higher cut-off values sUA levels might be useful in predicting COPD exacerbation risk and disease severity. However, more prospective cohort studies with large number of participants are needed to further analyse the possible different prognostic roles of hyperuricemia.


Salvi S. COPD: The neglected epidemic. Textbook of Pulmonary and Critical Care Medicine. Jindal SK, Jaypee Publications; 2011:971-974.

Jindal SK, Agarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, et al. Indian multi-centric study on epidemiology of asthma and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis. 2012 Sep;16(9):1270-7.

Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta–analysis. J Global Health. 2015 Dec;5(2).

Nicks ME, O'Brien MM, Bowler RP. Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers. COPD: J Chronic Obstruct Pulmonary Dis. 2011 Aug 18;8(4):264-9.

Woolliscroft JO, Colfer H, Fox IH. Hyperuricemia in Acute Illness: A Poor Prognostic Sign. Am J Med. 1982;72:58-62.

Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest. 2000 Jan 1;117(1):19-24.

Kang DH, Ha SK. Uric acid puzzle: Dual role as anti-oxidant and pro-oxidant. Electrolyte Blood Press. 2014;12:1-6.

Kadowaki T, Hamada H, Yokoyama A, Abe M, Nishimura K, Kohno N, et al. Significance of serum uric acid in patients with chronic respiratory failure treated with non-invasive positive pressure ventilation. Int Med. 2007;46(11):691-8.

Bartziokas K, Papaioannou AI, Loukides S, Papadopoulos A, Haniotou A, Papiris S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Europ Respirat J. 2014 Jan 1;43(1):43-53.

Bhatia A, Prakash V, Kant S, Verma AK. A search for covert precipitating clinical parameters in frequent exacerbators of chronic obstructive pulmonary disease. Lung India. 2016;33:600-4.

Sarangi R, Varadhan N, Bahinipati J, Dhinakaran A. Serum uric acid in chronic obstructive pulmonary disease: a hospital based case control study. J Clini Diagnos Res: JCDR. 2017 Sep;11(9):BC09-13.

Embarak S, Sileem AE, Abdrabboh M, Mokhtar A. Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. Egypt J Bronchol. 2014 Jul 1;8(2):115-20.

Galamay JR. Association of Serum Uric Acid Levels and Outcomes of Patients With COPD: A Prospective Cohort Study. Chest. 2017 Oct 1;152(4):A789.

Aida Y, Shibata Y, Osaka D, Abe S, Inoue S, Fukuzaki K, et al. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. Inter J Med Sci. 2011;8(6):470-8.

Horsfall LJ, Nazareth I, Petersen I. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014 Nov 1;69(11):1021-6.






Original Research Articles